Left Ventricular Diastolic Function in Hypertension: Methodological Considerations and Clinical Implications by Palmiero P et al.
Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press Inc™   |   www.jocmr.org
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction 
in any medium, provided the original work is properly cited
137
Review J Clin Med Res. 2015;7(3):137-144
ressElmer 
Left Ventricular Diastolic Function in Hypertension: 
Methodological Considerations and Clinical Implications
Pasquale Palmieroa, i, Annapaola Zitob, Maria Maielloa, Matteo Camelic, Pietro Amedeo Modestid, Maria 
Lorenza Muiesane, Salvatore Novof, Pier Sergio Sabag, Pietro Scicchitanob, Roberto Pedrinellih,  
Marco Matteo Cicconeb, on behalf of the Gruppo di Studio “Ipertensione, Prevenzione e Riabilitazione” della 
Societa Italiana di Cardiologia
Abstract
The assessment of left ventricular (LV) diastolic function should be 
an integral part of a routine examination of hypertensive patient; in-
deed when LV diastolic function is impaired, it is possible to have 
heart failure even with preserved LV ejection fraction. Left ventricu-
lar diastolic dysfunction (LVDD) occurs frequently and is associated 
to heart disease. Doppler echocardiography is the best tool for early 
LVDD diagnosis. Hypertension affects LV relaxation and when left 
ventricular hypertrophy (LVH) occurs, it decreases compliance too, 
so it is important to calculate Doppler echocardiography parameters, 
for diastolic function evaluation, in all hypertensive patients. The 
purpose of our review was to discuss about the strong relationship 
between LVDD and hypertension, and their relationship with LV 
systolic function. Furthermore, we aimed to assess the relationship 
between the arterial stiffness and LV structure and function in hyper-
tensive patients.
Keywords: Left ventricular; Diastolic function; Diastolic dysfunc-
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Introduction
Left ventricular diastolic dysfunction (LVDD) is an earlier 
alteration common to many cardiovascular diseases [1, 2]. 
Any kind of heart disease that leads to myocardial structural 
alteration and/or pericardial effusion may cause LVDD [1-3]. 
Sometimes this structural abnormality is evident macroscopi-
cally (i.e. hypertrophy, fibrosis, infiltrative diseases, dilated 
cardiomyopathy, myocardial infarction, constrictive pericar-
ditis, etc.). Other times, diastolic dysfunction is linked to ab-
normalities of the cellular mechanisms of myocyte relaxation 
caused by hypoxia and/or ischemia [3]. A lot of patients with 
congestive heart failure, symptomatic, have a normal left ven-
tricular ejection fraction and signs/symptoms mainly due to 
diastolic dysfunction [4, 5]. For these reasons, the assessment 
of LV diastolic function should be always performed during a 
routine echocardiographic examination, since when LV dias-
tolic function is impaired, it is possible to have heart failure 
even with preserved LV ejection fraction (HFpEF). Diastolic 
dysfunction can display a wide spectrum of different patterns, 
ranging from a simple slowing of ventricular relaxation, with-
out significant hemodynamic changes, to the development of 
pulmonary venous congestion, due to elevation of ventricular 
diastolic pressures with displacement of the pressure-volume 
loop in the upper and to the left [2, 3] (Fig. 1). However, pa-
tients affected by heart failure often presents both systolic and 
diastolic ventricular dysfunction, since the systole and diastole 
are related one to the other in a complex way. Often changes 
in diastolic function do not affect only the filling of the ven-
tricles, but also ventricular systolic function [6]. Many factors 
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can influence the ventricular diastolic filling and then the dias-
tolic pressure-volume relationship: coronary insufficiency [7], 
vasodilators and vasoconstrictors [8] (i.e. changes in preload 
and after load), geometric-mechanical interactions between 
the ventricles (e.g. reverse Bernheim effect in pulmonary em-
bolism) [9], pericardial anatomy [10] (e.g. constrictive peri-
carditis, pericardial effusion), metabolic alterations (acidosis, 
alkalosis) [11], cardiovascular drugs [12] (e.g. digital, beta-
blockers, calcium channel blockers), and hypoxia [13].
To better understand how LVDD occurs, we have to start 
from physiopathology of LV diastole. It can be divided into 
four phases, starting from aortic valve closure. The first phase 
of diastole is the isovolumic, which does not contribute to ven-
tricular filling. The second of early and rapid filling provides 
most of ventricular filling, about 60-90%. The third of slow 
filling, mentioned as diastasis, contributes to only 5% of the 
total filling. The final atrial booster phase normally accounts 
for the remaining 5-35%, according to the age, with an increas-
ing contribution in elderly [14] (Fig. 2).
“Isovolumic relaxation time” starts with the closure of 
the semilunar valves and ends with the opening of the atrio-
ventricular ones. During this phase, there is no change in in-
traventricular volume (because the valves are closed), but the 
geometric configuration of the ventricular cavity changes, fol-
lowed by a fall in ventricular pressure that becomes lower than 
atrial pressure. Then atrioventricular valve opens and it begins 
the second phase of diastole: fast ventricular filling [15]. The 
isovolumic relaxation is an energy-dependent process, where 
the calcium ions are removed from the cytoplasm against a 
concentration gradient, allowing the dissociation of the con-
tractile complex actin-myosin (active relaxation) [16]. It can 
be influenced, not only by the anatomical and functional heart 
conditions, but even from pre-load and post-load. The speed of 
relaxation also influences the speed of fall of left ventricular 
pressure. An impaired relaxation causes an increase in filling 
pressure to maintain an adequate diastolic volume of the ven-
tricle. Even the “elastic recovery” (the release of elastic energy 
“compressed” in the myocardium during the previous systole 
and then released as soon as the relaxation begins) acts on the 
isovolumic relaxation. Also this release contributes to the fall 
of left ventricular pressure at the beginning of diastole. A re-
duction in systolic function, resulting in an increase in left ven-
tricular end-systolic volume, causes a reduction of the “elastic 
return” in the subsequent early diastole. The gold standard 
measurement of relaxation rate is dP/dtmax, but it requires in-
vasive catheterization [17]. Similarly, tau, the time constant of 
relaxation, describes the rate of LV pressure decrease during 
isovolumic relaxation but it requires invasive techniques [18-
20]. On clinical practice, tau is assessed by echocardiography. 
Tau is increased as the systolic LV pressure increases. The iso-
volumic relaxation time can be measured by Doppler echo-
cardiography: it lies between aortic valve closure and mitral 
valve opening, but it suffers of an high intra- and inter-operator 
variability, so the range of normality is wide [20].
“Ventricular fast filling time” starts with the opening of 
the atrioventricular valve, proceeds with increasing speed up 
to a maximum peak, subsequently decelerates, and ends with 
the beginning of the third phase. During this phase, the blood 
which had accumulated in the atrium while the valve was 
closed is poured rapidly into the ventricle, consequently the 
atrial pressure falls while the ventricular pressure increases. 
The contribution of rapid ventricular filling to total diastolic 
one, in healthy adults, is about 65-80% [21]. “Fast ventricular 
filling time” is a mainly passive process, due to the atrioven-
tricular gradient, that is greatly influenced by ventricular com-
pliance. This phase of diastole is also influenced by the “elastic 
return” of the ventricle. In the “slow ventricular filling”, the 
flow of blood from the atrium to the ventricle is very slow, be-
cause the pressure gradient atrioventricular is virtually absent. 
The duration of this phase is greatly dependent on the heart 
rate [18-21]. “Atrial systole” is the final phase of diastole, pre-
sent only on sinus rhythm. Atrial active contraction causes an 
increase of blood flow from the atrium to the ventricle, con-
sequently an increase in pressure and volume occurs and the 
end-diastolic ventricular activation of Starling’s effect happens 
[4]. In normal subject, the contribution of atrial systole to the 
Figure 2. Diastolic phases related with changes in pressure (P) and volume (V) during a cardiac cycle. CI: isovolumic contraction; 
RI: isovolumic relaxation; RF: rapid filling. 
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total LV filling is about 20%. An increase in heart rate reduces 
the contribution of atrial systole. In arterial hypertension, LV 
filling abnormalities can be detected early and also, often, they 
precede the impairment of systolic function of the left ventri-
cle. In all phases of diastole, hypertension affects relaxation 
and when left ventricular hypertrophy (LVH) occurs, it reduces 
compliance too, so it is important to calculate Doppler echo-
cardiography parameters, for diastolic function evaluation, in 
all hypertensive patients. The goal of our paper is to assess the 
strong relationship between LVDD and hypertension, and their 
relationship with LV systolic function. We also want to inves-
tigate if there is a relation between the arterial stiffness and LV 
structure and function in hypertensive patients [22, 23].
The Assessment of LV Diastolic Function
LVDD is an important predictor of symptoms and clinical 
outcomes in patients with left ventricular systolic dysfunction 
(LVSD) [1, 2, 24]. Abnormalities of diastolic function in this 
population include an increase in LV filling pressures and LV 
volumes and impaired LV relaxation [25]. In a recent paper, 
“pre-clinical diastolic dysfunction” (PDD) has been defined 
as LVDD without congestive heart failure diagnosis and with 
normal systolic function [3]. Although invasive measures of 
LV relaxation and LV filling pressures (i.e., LV end-diastolic 
pressure) are considered to be the “gold standards” for the as-
sessment of diastolic function, they are not performed in stable 
outpatients with LVSD. Pulsed-wave Doppler (PWD)-derived 
transmitral inflow patterns are commonly used for assessment 
of LVDD [26-28].
However, patients with LVSD often have variability in 
PWD-derived indices of LVDD due to increases in LA pres-
sure, so they are preload-dependent [29, 30]. Tissue Doppler 
imaging (TDI)-derived early diastolic mitral annular velocity 
(E’) and color M-mode (CMM) imaging flow propagation ve-
locity (Vp) have been reported to be less load-dependent meth-
ods to assess LV relaxation [31-33].
In addition, the diastolic intraventricular pressure gradient 
(IVPG) can be derived from CMM imaging by mathematical 
calculations of the spatio-temporal distribution of the early di-
astolic blood flow velocities into the LV cavity [34, 35]. IVPG 
is reported to be a relatively preload-independent measurement 
of LV relaxation [36, 37]. The evaluation of diastolic function 
by TDI and CMM-derived measurements to assess diastolic 
function in patients with LVSD has not been well evaluated. 
The measurement of these myocardial parameters could be of 
great importance in patients with HFpEF because these echo-
cardiographic indices well describe the multidirectional func-
tion of whole LV myocardium, thereby allowing a detection of 
LV global function affections that is associated with a worse in 
symptomatic status of these patients.
LVDD and Prognosis
LVDD develops early in most cardiac diseases and leads to 
the elevation of LV filling pressures. Therefore, echocardio-
graphic measurements of diastolic function provide important 
prognostic information. E/A ratios (early phase of atrial filling 
phases) reflect the compensatory increase in the late (atrial) 
filling phase when hypertrophic LV fails to relax normally 
during diastole. The result is that the E/A ratio on the mitral 
Doppler pattern decreases or reverses. However, when LV 
hypertrophy increases and wall fibrosis develops, LV cham-
ber compliance decreases and the E wave again rises. Thus, it 
becomes difficult to separate E/A ratios that are truly normal 
from pseudonormal patterns of mitral inflow. Doppler tissue 
can measure the actual velocity of tissue relaxation of the mi-
tral valve annulus or the posterior wall. Clinical studies have 
Figure 3. Different patterns of LVDD by transmitral flow pattern (upper) and tissue Doppler at mitral annulus level (lower). DDT: 
diastolic deceleration time, E and e’m: early ventricular filling; A and a’m: atrial contraction. 
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shown the association of short mitral diastolic deceleration 
time (DDT) with heart failure, death and hospitalizations in 
patients with acute myocardial infarction [38-54] (Fig. 3). Di-
astolic measurements provide incremental information to wall 
motion score index, as assessed by a recent meta-analysis of 12 
post-acute myocardial infarction studies involving 1,286 pa-
tients [55]. Similar findings were reported in patients with is-
chemic or dilated cardiomyopathy, including atrial fibrillation. 
Pulmonary venous velocities [42, 56-58] and Vp [59] were 
less frequently performed but were still predictive of clinical 
events [60, 61]. Given the variability in measuring DT, Vp, 
and pulmonary venous flow velocity duration, recent studies 
have examined the prognostic value of E/E1. Several studies 
[62-74] have shown that E/E1 is highly predictive of adverse 
events after acute myocardial infarction and in hypertensive 
cardiomyopathy, severe secondary mitral regurgitation (MR), 
end-stage renal disease, atrial fibrillation, and cardiomyopath-
ic disorders. The E/E1 ratio is among the most reproducible 
echocardiographic parameter to estimate pulmonary capillary 
wedge pressure and is the preferred prognostic parameter in 
many cardiac conditions. While all Doppler parameters above-
mentioned estimate LVDD at moment of the performance, left 
atrial structural and functional remodeling parameters have 
been proposed as a barometer of diastolic burden over time 
and as predictor of common cardiovascular outcomes, such as 
atrial fibrillation, stroke, congestive heart failure, and cardio-
vascular death [75, 76].
Aortic stiffness
Aortic stiffening is increasingly recognized as an early marker 
of future cardiovascular disease and mortality among general 
population and hypertensive patients [77-80].
Classic risk scores may underestimate the risk of cardio-
vascular events in specific groups suitable for early preven-
tion, such as asymptomatic hypertensive patients, often being 
wrongly classified as at low or moderate risk. Arterial stiff-
ness is the most important determinant of increasing systolic 
and pulse pressures in ageing societies, thus giving a relevant 
contribution to incidence of stroke and myocardial infarction. 
Arterial stiffness has a predictive value for cardiovascular 
events, beyond classical cardiovascular risk  factors and gives 
direct evidence of target organ damage, being itself a “tissue 
biomarker” [81]. Increased aortic stiffness is considered to be 
involved into artery’s ageing process [79], it determinates an 
increase in systolic blood pressure (SBP) and a decrease in 
diastolic blood pressure (DBP) resulting in an augmented LV 
workload and reduced perfusion of the coronary arteries dur-
ing diastole [81]. Increased aortic stiffness, a major mechani-
cal factor predicting CV risk, has been well identified as play-
ing a role in metabolic syndrome. Its age progression seems 
to be proportional to the number of risk factors involved in 
metabolic syndrome and is responsible for increased SBP and 
decreased DBP with increasing age, the principal hallmarks 
of hypertension in the elderly [78]. Aortic stiffness is assessed 
by PWVg measured using two-dimensional (2D) echocardi-
ography. The PWVg is calculated between the aortic valve 
and right common femoral artery by dividing the straight line 
distance between the two by the transit time. The distance is 
assessed using a tape measure located at the same place as the 
ultrasound probe. The transit time was defined as the differ-
ence between two intervals of time using the Doppler method 
[82]. PWVg is a simple, accurate, noninvasive means for the 
determination of large-artery stiffness, and it does not require 
dedicated equipment because it is performable by common 
echocardiographic machine, does not need training and is not 
time consuming [80]. Aortic PWV is considered an intrinsic 
measure of arterial stiffness according to the Moens-Korteweg 
equation where PWV is proportional to the square root of the 
incremental elastic modulus, of the vessel wall given constant 
ratio of wall thickness, to vessel radius and blood density, as-
suming that the artery wall is isotropic and experiences isovol-
umetric change with pulse pressure [80]. So PWV is related to 
the pulsatile component of LV afterload and is linked to prog-
nostically adverse cardiac phenotype, including depressed LV 
systolic function [83, 84]. The strong relation between PWV 
and LV is also true because the pulse wave is generated by 
the contracting heart, and aortic PWV might be partially deter-
mined by enhanced myocardial performance, with a shortened 
LV ejection time, in young subjects [82]. If the initial speed 
of the pressure wave is mainly determined by the velocity of 
myocardial shortening [85] and LV ejection time is related 
with shortening velocity [86], we can assess that myocardial 
function and pulse pressure influence each other. The relation 
between aortic PWV and LV mass and function have been un-
derstudied until recent years. However, it may support a better 
comprehension of mechanism of HFpEF, a condition associ-
ated with high morbidity and mortality, whose prevalence is 
increasing, and is common among postmenopausal women. 
There are sex differences in aortic stiffness and its influence 
on left ventricle mass, geometry and function, postmenopausal 
women display increased arterial and LV stiffening, so LVDD 
[87, 88]. In addition, the association of increased arterial stiff-
ness with mortality is almost two-fold higher in women than 
in men [89].
Conclusions
Although LVDD  remains poorly understood, it has an impor-
tant clinical significance. LV diastolic function is influenced 
by arterial stiffness, changing the different components of its 
load, modulates LV structure and function. In patients affected 
by arterial hypertension, the pressure-volume loop shifts to the 
upper right side, therefore, pulmonary congestion is induced by 
a significant increase in LV end-diastolic pressure. To preserve 
LV ejection fraction, the pressure-volume loop shifts right due 
to a preload increase. Therefore, the LV pressure-volume loop 
operates on the ascending section of the end-diastolic pressure-
volume curve, consequently causing end-diastolic pressure to 
arise. There is a strong relationship between arterial stiffness 
and the diastolic properties of the left ventricle. With increas-
ing age, arterial stiffness becomes related to LV hypertrophy 
and to impaired LV diastolic function [77, 78, 90]. Aortic stiff-
ness is related to electrocardiographically determined LVH in 
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patients with hypertension [79]. Aortic PWVg is widely used 
to estimate arterial stiffness as elastic properties of the arterial 
tree and it is a strong predictor of cardiovascular outcomes in 
different clinical settings, including essential hypertension [91, 
92]. Large artery stiffness is related to an array of functional 
and structural changes of the left ventricle [88, 93-95]. An el-
evated aortic impedance is a major stimulus for the develop-
ment of LV unfavorable changes in diastolic function and a 
significant increase in LV mass. The more possible complete 
study of LV diastolic function and arterial stiffness leads to 
a complete detection of different mechanisms involved into 
complex functional and structural modifications of the hyper-
tensive heart.
References
1. Wiegers SE. Diastolic echo parameters: meaningless 
numbers or crucial information? Circ Cardiovasc Imag-
ing. 2011;4(5):460-462.
2. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh 
JK, Smiseth OA, Waggoner AD, et al. Recommendations 
for the evaluation of left ventricular diastolic function by 
echocardiography. Eur J Echocardiogr. 2009;10(2):165-
193.
3. Wan SH, Vogel MW, Chen HH. Pre-clinical diastolic dys-
function. J Am Coll Cardiol. 2014;63(5):407-416.
4. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure-
-abnormalities in active relaxation and passive stiffness 
of the left ventricle. N Engl J Med. 2004;350(19):1953-
1959.
5. Vasan RS, Levy D. Defining diastolic heart failure: a 
call for standardized diagnostic criteria. Circulation. 
2000;101(17):2118-2121.
6. Quiroz R, Doros G, Shaw P, Liang CS, Gauthier DF, Sam 
F. Comparison of characteristics and outcomes of patients 
with heart failure preserved ejection fraction versus re-
duced left ventricular ejection fraction in an urban cohort. 
Am J Cardiol. 2014;113(4):691-696.
7. Mitu F, Mitu M. [Clinical aspects of the left ventricular 
diastolic dysfunction at patients with coronary heart dis-
ease]. Rev Med Chir Soc Med Nat Iasi. 2001;105(4):733-
739.
8. Wang J, Guan W, Chen D, Han Y, Xu Z, Qiang J, Chen W, 
et al. The value of CTPA for diagnosing acute pulmonary 
thromboembolism and the ensuing right ventricular dys-
function. Cell Biochem Biophys. 2014;69(3):517-522.
9. McCabe C, White PA, Hoole SP, Axell RG, Priest AN, Go-
palan D, Taboada D, et al. Right ventricular dysfunction 
in chronic thromboembolic obstruction of the pulmonary 
artery: a pressure-volume study using the conductance 
catheter. J Appl Physiol (1985). 2014;116(4):355-363.
10. Morishima S, Sakai H, Okazaki A. [Anesthetic manage-
ment of a hemodialysis patient presenting with appar-
ent LV diastolic dysfunction after undergoing extensive 
pericardiectomy for constrictive pericarditis]. Masui. 
2014;63(2):175-179.
11. Nogueira JB. [Hypertensive cardiopathy. From arterial 
hypertension to congestive heart failure]. Rev Port Car-
diol. 1999;18(6):635-646.
12. Lim S, Chang W, Cha MJ, Song BW, Ham O, Lee SY, Lee 
C, et al. PLCdelta1 protein rescues ischemia-reperfused 
heart by the regulation of calcium homeostasis. Mol Ther. 
2014;22(6):1110-1121.
13. Pandit A, Mookadam F, Hakim FA, Mulroy E, Saadiq R, 
Doherty M, Cha S, et al. Ia Diastolic Dysfunction: An 
Echocardiographic Grade. Echocardiography. 2014.
14. Afolabi-Brown OO, Lynn Morris D, Pressman GS. Sys-
tolic mitral valve opening and absent isovolumic relaxa-
tion: unusual hemodynamics of severe mitral regurgita-
tion. Echocardiography. 2014;31(6):E189-190.
15. Pouleur H. Diastolic dysfunction and myocardial energet-
ics. Eur Heart J. 1990;11(Suppl C):30-34.
16. Tzschatzsch H, Hattasch R, Knebel F, Klaua R, Schultz 
M, Jenderka KV, Braun J, et al. Isovolumetric elastic-
ity alteration in the human heart detected by in vivo 
time-harmonic elastography. Ultrasound Med Biol. 
2013;39(12):2272-2278.
17. Frais MA, Bergman DW, Kingma I, Smiseth OA, Smith 
ER, Tyberg JV. The dependence of the time constant of 
left ventricular isovolumic relaxation (tau) on pericardial 
pressure. Circulation. 1990;81(3):1071-1080.
18. Gaasch WH, Blaustein AS, Andrias CW, Donahue RP, 
Avitall B. Myocardial relaxation. II. Hemodynamic de-
terminants of rate of left ventricular isovolumic pressure 
decline. Am J Physiol. 1980;239(1):H1-6.
19. Zile MR, Gaasch WH. Mechanical loads and the isovolu-
mic and filling indices of left ventricular relaxation. Prog 
Cardiovasc Dis. 1990;32(5):333-346.
20. Pfaffenberger S, Bartko P, Graf A, Pernicka E, Babayev 
J, Lolic E, Bonderman D, et al. Size matters! Impact of 
age, sex, height, and weight on the normal heart size. Circ 
Cardiovasc Imaging. 2013;6(6):1073-1079.
21. Miyoshi H, Oishi Y, Mizuguchi Y, Iuchi A, Nagase N, 
Ara N, Oki T. Influence of comorbid cardiovascular 
risk factors on left atrial-left ventricular interaction in 
asymptomatic patients: clinical application of two-di-
mensional speckle-tracking echocardiography. Int Heart 
J. 2014;55(2):138-145.
22. Krzesiak-Lodyga A, Cwetsch A. [Echocardiographic 
methods for assessment of left ventricular diastolic 
dysfunction--state of the art]. Pol Merkur Lekarski. 
2013;35(206):63-66.
23. Zile MR, Gaasch WH, Carroll JD, Feldman MD, Au-
rigemma GP, Schaer GL, Ghali JK, et al. Heart failure 
with a normal ejection fraction: is measurement of dias-
tolic function necessary to make the diagnosis of diastolic 
heart failure? Circulation. 2001;104(7):779-782.
24. Lang RM, Bierig M, Devereux RB, Flachskampf FA, 
Foster E, Pellikka PA, Picard MH, et al. Recommen-
dations for chamber quantification: a report from the 
American Society of Echocardiography's Guidelines and 
Standards Committee and the Chamber Quantification 
Writing Group, developed in conjunction with the Euro-
pean Association of Echocardiography, a branch of the 
European Society of Cardiology. J Am Soc Echocardiogr. 
Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press Inc™   |   www.jocmr.org142
LVDD in Hypertension J Clin Med Res. 2015;7(3):137-144
2005;18(12):1440-1463.
25. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss 
CK, Levy D. Congestive heart failure in subjects with 
normal versus reduced left ventricular ejection fraction: 
prevalence and mortality in a population-based cohort. J 
Am Coll Cardiol. 1999;33(7):1948-1955.
26. Eichhorn EJ, Willard JE, Alvarez L, Kim AS, Glamann 
DB, Risser RC, Grayburn PA. Are contraction and relaxa-
tion coupled in patients with and without congestive heart 
failure? Circulation. 1992;85(6):2132-2139.
27. Naqvi TZ, Neyman G, Broyde A, Mustafa J, Siegel RJ. 
Comparison of myocardial tissue Doppler with transmi-
tral flow Doppler in left ventricular hypertrophy. J Am 
Soc Echocardiogr. 2001;14(12):1153-1160.
28. Schannwell CM, Schneppenheim M, Plehn G, Marx R, 
Strauer BE. Left ventricular diastolic function in physi-
ologic and pathologic hypertrophy. Am J Hypertens. 
2002;15(6):513-517.
29. Schillaci G, Pasqualini L, Verdecchia P, Vaudo G, Marche-
si S, Porcellati C, de Simone G, et al. Prognostic signifi-
cance of left ventricular diastolic dysfunction in essential 
hypertension. J Am Coll Cardiol. 2002;39(12):2005-
2011.
30. Harizi RC, Bianco JA, Alpert JS. Diastolic function 
of the heart in clinical cardiology. Arch Intern Med. 
1988;148(1):99-109.
31. Garcia MJ, Smedira NG, Greenberg NL, Main M, Firsten-
berg MS, Odabashian J, Thomas JD. Color M-mode Dop-
pler flow propagation velocity is a preload insensitive 
index of left ventricular relaxation: animal and human 
validation. J Am Coll Cardiol. 2000;35(1):201-208.
32. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh 
JK, Redfield MM, Tajik AJ. Clinical utility of Doppler 
echocardiography and tissue Doppler imaging in the esti-
mation of left ventricular filling pressures: A comparative 
simultaneous Doppler-catheterization study. Circulation. 
2000;102(15):1788-1794.
33. De Boeck BW, Oh JK, Vandervoort PM, Vierendeels JA, 
van der Aa RP, Cramer MJ. Colour M-mode velocity 
propagation: a glance at intra-ventricular pressure gra-
dients and early diastolic ventricular performance. Eur J 
Heart Fail. 2005;7(1):19-28.
34. Chamoun AJ, Xie T, McCullough M, Birnbaum Y, Ah-
mad M. Color M-mode flow propagation velocity and 
conventional doppler indices in the assessment of dias-
tolic left ventricular function during isometric exercise. 
Echocardiography. 2005;22(5):380-388.
35. Bermejo J, Antoranz JC, Yotti R, Moreno M, Garcia-
Fernandez MA. Spatio-temporal mapping of intracardiac 
pressure gradients. A solution to Euler's equation from 
digital postprocessing of color Doppler M-mode echocar-
diograms. Ultrasound Med Biol. 2001;27(5):621-630.
36. Greenberg NL, Vandervoort PM, Firstenberg MS, Garcia 
MJ, Thomas JD. Estimation of diastolic intraventricular 
pressure gradients by Doppler M-mode echocardiography. 
Am J Physiol Heart Circ Physiol. 2001;280(6):H2507-
2515.
37. Firstenberg MS, Smedira NG, Greenberg NL, Prior DL, 
McCarthy PM, Garcia MJ, Thomas JD. Relationship be-
tween early diastolic intraventricular pressure gradients, 
an index of elastic recoil, and improvements in systolic 
and diastolic function. Circulation. 2001;104(12 Suppl 
1):I330-335.
38. Xie GY, Berk MR, Smith MD, Gurley JC, DeMaria AN. 
Prognostic value of Doppler transmitral flow patterns in 
patients with congestive heart failure. J Am Coll Cardiol. 
1994;24(1):132-139.
39. Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ. 
Systolic and diastolic dysfunction in patients with clinical 
diagnosis of dilated cardiomyopathy. Relation to symp-
toms and prognosis. Circulation. 1994;90(6):2772-2779.
40. Traversi E, Pozzoli M, Cioffi G, Capomolla S, Forni G, 
Sanarico M, Tavazzi L. Mitral flow velocity changes after 
6 months of optimized therapy provide important hemo-
dynamic and prognostic information in patients with 
chronic heart failure. Am Heart J. 1996;132(4):809-819.
41. Giannuzzi P, Temporelli PL, Bosimini E, Silva P, Im-
parato A, Corra U, Galli M, et al. Independent and in-
cremental prognostic value of Doppler-derived mitral 
deceleration time of early filling in both symptomatic and 
asymptomatic patients with left ventricular dysfunction. J 
Am Coll Cardiol. 1996;28(2):383-390.
42. Hurrell DG, Oh JK, Mahoney DW, Miller FA, Jr., Seward 
JB. Short deceleration time of mitral inflow E velocity: 
prognostic implication with atrial fibrillation versus sinus 
rhythm. J Am Soc Echocardiogr. 1998;11(5):450-457.
43. Hansen A, Haass M, Zugck C, Krueger C, Unnebrink K, 
Zimmermann R, Kuebler W, et al. Prognostic value of 
Doppler echocardiographic mitral inflow patterns: impli-
cations for risk stratification in patients with chronic con-
gestive heart failure. J Am Coll Cardiol. 2001;37(4):1049-
1055.
44. Faris R, Coats AJ, Henein MY. Echocardiography-derived 
variables predict outcome in patients with nonischemic 
dilated cardiomyopathy with or without a restrictive fill-
ing pattern. Am Heart J. 2002;144(2):343-350.
45. Whalley GA, Doughty RN, Gamble GD, Wright SP, 
Walsh HJ, Muncaster SA, Sharpe N. Pseudonormal mi-
tral filling pattern predicts hospital re-admission in pa-
tients with congestive heart failure. J Am Coll Cardiol. 
2002;39(11):1787-1795.
46. Rossi A, Cicoira M, Golia G, Zanolla L, Franceschini L, 
Marino P, Graziani M, et al. Amino-terminal propeptide 
of type III procollagen is associated with restrictive mitral 
filling pattern in patients with dilated cardiomyopathy: a 
possible link between diastolic dysfunction and progno-
sis. Heart. 2004;90(6):650-654.
47. Bella JN, Palmieri V, Roman MJ, Liu JE, Welty TK, Lee 
ET, Fabsitz RR, et al. Mitral ratio of peak early to late 
diastolic filling velocity as a predictor of mortality in 
middle-aged and elderly adults: the Strong Heart Study. 
Circulation. 2002;105(16):1928-1933.
48. Pozzoli M, Traversi E, Cioffi G, Stenner R, Sanarico M, 
Tavazzi L. Loading manipulations improve the prognos-
tic value of Doppler evaluation of mitral flow in patients 
with chronic heart failure. Circulation. 1997;95(5):1222-
Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press Inc™   |   www.jocmr.org 143
Palmiero et al J Clin Med Res. 2015;7(3):137-144
1230.
49. Pinamonti B, Zecchin M, Di Lenarda A, Gregori D, Sina-
gra G, Camerini F. Persistence of restrictive left ventricu-
lar filling pattern in dilated cardiomyopathy: an ominous 
prognostic sign. J Am Coll Cardiol. 1997;29(3):604-612.
50. Temporelli PL, Corra U, Imparato A, Bosimini E, Scapel-
lato F, Giannuzzi P. Reversible restrictive left ventricu-
lar diastolic filling with optimized oral therapy predicts 
a more favorable prognosis in patients with chronic heart 
failure. J Am Coll Cardiol. 1998;31(7):1591-1597.
51. Oh JK, Ding ZP, Gersh BJ, Bailey KR, Tajik AJ. Restric-
tive left ventricular diastolic filling identifies patients 
with heart failure after acute myocardial infarction. J Am 
Soc Echocardiogr. 1992;5(5):497-503.
52. Pozzoli M, Capomolla S, Sanarico M, Pinna G, Cobelli 
F, Tavazzi L. Doppler evaluations of left ventricular di-
astolic filling and pulmonary wedge pressure provide 
similar prognostic information in patients with systolic 
dysfunction after myocardial infarction. Am Heart J. 
1995;129(4):716-725.
53. Nijland F, Kamp O, Karreman AJ, van Eenige MJ, Vis-
ser CA. Prognostic implications of restrictive left ven-
tricular filling in acute myocardial infarction: a serial 
Doppler echocardiographic study. J Am Coll Cardiol. 
1997;30(7):1618-1624.
54. Sakata K, Kashiro S, Hirata S, Yanagisawa A, Ishikawa 
K. Prognostic value of Doppler transmitral flow veloc-
ity patterns in acute myocardial infarction. Am J Cardiol. 
1997;79(9):1165-1169.
55. Somaratne JB, Whalley GA, Gamble GD, Doughty RN. 
Restrictive filling pattern is a powerful predictor of heart 
failure events postacute myocardial infarction and in es-
tablished heart failure: a literature-based meta-analysis. J 
Card Fail. 2007;13(5):346-352.
56. Poulsen SH, Jensen SE, Gotzsche O, Egstrup K. Evalu-
ation and prognostic significance of left ventricular dias-
tolic function assessed by Doppler echocardiography in 
the early phase of a first acute myocardial infarction. Eur 
Heart J. 1997;18(12):1882-1889.
57. Dini FL, Michelassi C, Micheli G, Rovai D. Prognostic 
value of pulmonary venous flow Doppler signal in left 
ventricular dysfunction: contribution of the difference in 
duration of pulmonary venous and mitral flow at atrial 
contraction. J Am Coll Cardiol. 2000;36(4):1295-1302.
58. Dini FL, Dell'Anna R, Micheli A, Michelassi C, Rovai 
D. Impact of blunted pulmonary venous flow on the out-
come of patients with left ventricular systolic dysfunction 
secondary to either ischemic or idiopathic dilated cardio-
myopathy. Am J Cardiol. 2000;85(12):1455-1460.
59. Moller JE, Sondergaard E, Seward JB, Appleton CP, Eg-
strup K. Ratio of left ventricular peak E-wave velocity 
to flow propagation velocity assessed by color M-mode 
Doppler echocardiography in first myocardial infarction: 
prognostic and clinical implications. J Am Coll Cardiol. 
2000;35(2):363-370.
60. Moller JE, Sondergaard E, Poulsen SH, Egstrup K. Pseu-
donormal and restrictive filling patterns predict left ven-
tricular dilation and cardiac death after a first myocardial 
infarction: a serial color M-mode Doppler echocardio-
graphic study. J Am Coll Cardiol. 2000;36(6):1841-1846.
61. Moller JE, Sondergaard E, Poulsen SH, Seward JB, Ap-
pleton CP, Egstrup K. Color M-mode and pulsed wave 
tissue Doppler echocardiography: powerful predictors of 
cardiac events after first myocardial infarction. J Am Soc 
Echocardiogr. 2001;14(8):757-763.
62. Troughton RW, Prior DL, Frampton CM, Nash PJ, Pereira 
JJ, Martin M, Fogarty A, et al. Usefulness of tissue dop-
pler and color M-mode indexes of left ventricular di-
astolic function in predicting outcomes in systolic left 
ventricular heart failure (from the ADEPT study). Am J 
Cardiol. 2005;96(2):257-262.
63. Wang M, Yip GW, Wang AY, Zhang Y, Ho PY, Tse 
MK, Lam PK, et al. Peak early diastolic mitral annulus 
velocity by tissue Doppler imaging adds independent 
and incremental prognostic value. J Am Coll Cardiol. 
2003;41(5):820-826.
64. Yamamoto T, Oki T, Yamada H, Tanaka H, Ishimoto T, 
Wakatsuki T, Tabata T, et al. Prognostic value of the atrial 
systolic mitral annular motion velocity in patients with 
left ventricular systolic dysfunction. J Am Soc Echocar-
diogr. 2003;16(4):333-339.
65. Redfield MM, Jacobsen SJ, Burnett JC, Jr., Mahoney 
DW, Bailey KR, Rodeheffer RJ. Burden of systolic and 
diastolic ventricular dysfunction in the community: ap-
preciating the scope of the heart failure epidemic. JAMA. 
2003;289(2):194-202.
66. Hillis GS, Moller JE, Pellikka PA, Gersh BJ, Wright RS, 
Ommen SR, Reeder GS, et al. Noninvasive estimation of 
left ventricular filling pressure by E/e' is a powerful pre-
dictor of survival after acute myocardial infarction. J Am 
Coll Cardiol. 2004;43(3):360-367.
67. Wang M, Yip G, Yu CM, Zhang Q, Zhang Y, Tse D, Kong 
SL, et al. Independent and incremental prognostic value 
of early mitral annulus velocity in patients with impaired 
left ventricular systolic function. J Am Coll Cardiol. 
2005;45(2):272-277.
68. Dokainish H, Zoghbi WA, Lakkis NM, Ambriz E, Patel R, 
Quinones MA, Nagueh SF. Incremental predictive power 
of B-type natriuretic peptide and tissue Doppler echocar-
diography in the prognosis of patients with congestive 
heart failure. J Am Coll Cardiol. 2005;45(8):1223-1226.
69. Wang M, Yip GW, Wang AY, Zhang Y, Ho PY, Tse MK, 
Yu CM, et al. Tissue Doppler imaging provides incre-
mental prognostic value in patients with systemic hy-
pertension and left ventricular hypertrophy. J Hypertens. 
2005;23(1):183-191.
70. Sharma R, Pellerin D, Gaze DC, Mehta RL, Gregson H, 
Streather CP, Collinson PO, et al. Mitral peak Doppler E-
wave to peak mitral annulus velocity ratio is an accurate 
estimate of left ventricular filling pressure and predicts 
mortality in end-stage renal disease. J Am Soc Echocardi-
ogr. 2006;19(3):266-273.
71. Okura H, Takada Y, Kubo T, Iwata K, Mizoguchi S, Ta-
guchi H, Toda I, et al. Tissue Doppler-derived index of 
left ventricular filling pressure, E/E', predicts survival 
of patients with non-valvular atrial fibrillation. Heart. 
Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press Inc™   |   www.jocmr.org144
LVDD in Hypertension J Clin Med Res. 2015;7(3):137-144
2006;92(9):1248-1252.
72. Bruch C, Klem I, Breithardt G, Wichter T, Gradaus R. 
Diagnostic usefulness and prognostic implications of 
the mitral E/E' ratio in patients with heart failure and 
severe secondary mitral regurgitation. Am J Cardiol. 
2007;100(5):860-865.
73. McMahon CJ, Nagueh SF, Pignatelli RH, Denfield SW, 
Dreyer WJ, Price JF, Clunie S, et al. Characterization of 
left ventricular diastolic function by tissue Doppler imag-
ing and clinical status in children with hypertrophic car-
diomyopathy. Circulation. 2004;109(14):1756-1762.
74. McMahon CJ, Nagueh SF, Eapen RS, Dreyer WJ, Fin-
kelshtyn I, Cao X, Eidem BW, et al. Echocardiographic 
predictors of adverse clinical events in children with di-
lated cardiomyopathy: a prospective clinical study. Heart. 
2004;90(8):908-915.
75. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. 
Left atrial volume as a morphophysiologic expression of 
left ventricular diastolic dysfunction and relation to cardi-
ovascular risk burden. Am J Cardiol. 2002;90(12):1284-
1289.
76. Cameli M, Lisi M, Focardi M, Reccia R, Natali BM, 
Sparla S, Mondillo S. Left atrial deformation analysis by 
speckle tracking echocardiography for prediction of car-
diovascular outcomes. Am J Cardiol. 2012;110(2):264-
269.
77. O'Rourke MF. The arterial pulse in health and disease. 
Am Heart J. 1971;82(5):687-702.
78. Brilla CG, Janicki JS, Weber KT. Impaired diastolic func-
tion and coronary reserve in genetic hypertension. Role of 
interstitial fibrosis and medial thickening of intramyocar-
dial coronary arteries. Circ Res. 1991;69(1):107-115.
79. Emoto M, Nishizawa Y, Kawagishi T, Maekawa K, Hiura 
Y, Kanda H, Izumotani K, et al. Stiffness indexes beta 
of the common carotid and femoral arteries are associ-
ated with insulin resistance in NIDDM. Diabetes Care. 
1998;21(7):1178-1182.
80. Palmiero P, Maiello M, Daly DD, Jr., Ciccone MM, Nan-
da NC. Aortic stiffness assessed by global pulse wave 
velocity in postmenopausal women: an ultrasonographic 
study. Echocardiography. 2012;29(10):1233-1238.
81. Laurent S, Alivon M, Beaussier H, Boutouyrie P. Aortic 
stiffness as a tissue biomarker for predicting future cardi-
ovascular events in asymptomatic hypertensive subjects. 
Ann Med. 2012;44(Suppl 1):S93-97.
82. Coutinho T, Turner ST, Kullo IJ. Aortic pulse wave veloc-
ity is associated with measures of subclinical target organ 
damage. JACC Cardiovasc Imaging. 2011;4(7):754-761.
83. Gosling RG, Budge MM. Terminology for describ-
ing the elastic behavior of arteries. Hypertension. 
2003;41(6):1180-1182.
84. Bortolotto LA, Blacher J, Kondo T, Takazawa K, Safar 
ME. Assessment of vascular aging and atherosclerosis in 
hypertensive subjects: second derivative of photoplethys-
mogram versus pulse wave velocity. Am J Hypertens. 
2000;13(2):165-171.
85. Banks K, Puttagunta D, Murphy S, Lo M, McGuire DK, 
de Lemos JA, Chang AY, et al. Clinical characteristics, 
vascular function, and inflammation in women with angi-
na in the absence of coronary atherosclerosis: the Dallas 
Heart Study. JACC Cardiovasc Imaging. 2011;4(1):65-
73.
86. Georgianos PI, Sarafidis PA, Malindretos P, Nikolaidis P, 
Lasaridis AN. Hemodialysis reduces augmentation index 
but not aortic or brachial pulse wave velocity in dialysis-
requiring patients. Am J Nephrol. 2011;34(5):407-414.
87. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, 
London GM. Impact of aortic stiffness on survival in end-
stage renal disease. Circulation. 1999;99(18):2434-2439.
88. Greenwald SE. Ageing of the conduit arteries. J Pathol. 
2007;211(2):157-172.
89. Safar ME, Laurent S, Pannier BM, London GM. Struc-
tural and functional modifications of peripheral large 
arteries in hypertensive patients. J Clin Hypertens. 
1987;3(3):360-367.
90. Baguet JP, Kingwell BA, Dart AL, Shaw J, Ferrier KE, 
Jennings GL. Analysis of the regional pulse wave veloc-
ity by Doppler: methodology and reproducibility. J Hum 
Hypertens. 2003;17(6):407-412.
91. Chung CM, Lin YS, Chu CM, Chang ST, Cheng HW, 
Yang TY, Hsiao JF, et al. Arterial stiffness is the inde-
pendent factor of left ventricular hypertrophy determined 
by electrocardiogram. Am J Med Sci. 2012;344(3):190-
193.
92. Benetos A, Laurent S, Hoeks AP, Boutouyrie PH, Safar 
ME. Arterial alterations with aging and high blood pres-
sure. A noninvasive study of carotid and femoral arteries. 
Arterioscler Thromb. 1993;13(1):90-97.
93. Sowers MF, Karvonen-Gutierrez CA, Yosef M, Jannausch 
M, Jiang Y, Garnero P, Jacobson J. Longitudinal changes 
of serum COMP and urinary CTX-II predict X-ray de-
fined knee osteoarthritis severity and stiffness in women. 
Osteoarthritis Cartilage. 2009;17(12):1609-1614.
94. Coutinho T, Borlaug BA, Pellikka PA, Turner ST, Kullo 
IJ. Sex differences in arterial stiffness and ventricular-ar-
terial interactions. J Am Coll Cardiol. 2013;61(1):96-103.
95. Okamura T, Moriyama Y, Kadowaki T, Kanda H, Ueshi-
ma H. Non-invasive measurement of brachial-ankle pulse 
wave velocity is associated with serum C-reactive protein 
but not with alpha-tocopherol in Japanese middle-aged 
male workers. Hypertens Res. 2004;27(3):173-180.
